melatonin has been researched along with Fibroid in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 7.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
| "Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 5.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
| "In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 3.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
| "Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 1.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, PH | 1 |
| Tung, YT | 1 |
| Chen, HY | 1 |
| Chiang, YF | 1 |
| Hong, HC | 1 |
| Huang, KC | 1 |
| Hsu, SP | 1 |
| Huang, TC | 1 |
| Hsia, SM | 1 |
| Bartsch, C | 1 |
| Bartsch, H | 1 |
| Karenovics, A | 1 |
| Franz, H | 1 |
| Peiker, G | 1 |
| Mecke, D | 1 |
2 other studies available for melatonin and Fibroid
| Article | Year |
|---|---|
Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Humans; Leio | 2020 |
Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
Topics: Breast Neoplasms; Female; Fibroadenoma; Fibrocystic Breast Disease; Humans; Leiomyoma; Melatonin; Mi | 1997 |